Pfizer says booster COVID-19 shot warranted in FDA document

Pfizer Inc said that U.S. regulators should approve a booster dose of the COVID-19 vaccine it developed with Germany’s BioNTech SA six months after the second dose due to waning effectiveness of the shot over time, according to documents the drugmaker submitted to the U.S. Food and Drug Administration. The FDA released the documents on […]
Read More